Wolfgang Warsch

2.0k citations
16 papers · 1.2k indexed · h-index 14
Topics
Chronic Myeloid Leukemia Treatments (11 papers)Eosinophilic Disorders and Syndromes (9 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers)

In The Last Decade

Wolfgang Warsch

16 papers receiving 1.2k citations

Peers

Wolfgang Warsch
Comparison fields: 5 of 67
  • Hematology 637
  • Genetics 427
  • Oncology 415
  • Immunology 401
  • Molecular Biology 381
Replace M. Golam Mohi with:
M. Golam Mohi United States
Virginia Kelly United States
Ryan P. Million United States
Rebekka Grundler Germany
Véronique Della Valle France
Daniel W. Sherbenou United States
Po Yee Mak United States
J V Melo United Kingdom
Niove E. Jordanides United Kingdom
YinWei Ho United States
Wolfgang Warsch relative to M. Golam Mohi United States M. Golam Mohi's profile →
Citations per field
00.5×1.5×1.8×
M. Golam Mohi · 1×
Citations per year

Countries citing papers authored by Wolfgang Warsch

Since Specialization
Citations

This map shows the geographic impact of Wolfgang Warsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Warsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Warsch more than expected).

Fields of papers citing papers by Wolfgang Warsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Warsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Warsch. The network helps show where Wolfgang Warsch may publish in the future.

Co-authorship network of co-authors of Wolfgang Warsch

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Warsch. A scholar is included among the top collaborators of Wolfgang Warsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Warsch. Wolfgang Warsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 34
2 43
3 39
4 46
5 1
6 76
7 49
8 131
9 60
10 148
11 1
12 27
13 185
14 169
15 38
16 168

About Wolfgang Warsch

Wolfgang Warsch is a scholar working on Hematology, Genetics and Rheumatology, having authored 16 papers that have together received 1.2k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (11 papers), Eosinophilic Disorders and Syndromes (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). The work is most often cited by research in Hematology (637 citations), Genetics (427 citations) and Immunology (401 citations). Wolfgang Warsch has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Veronika Sexl, Eva Eckelhart, Richard Moriggl, Andrea Hoelbl‐Kovacic, Olivia Simma, Lothar Hennighausen, Hartmut Beug, Boris Kovačic, Florian Grebien and Sabine Fajmann. Their work appears in journals such as Blood, Nature Chemical Biology and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026